Salvage brachytherapy after external-beam irradation for prostate cancer

ONCOLOGY

Volumn 18, Issue 2, 2004, Pages 151-158

  Beyer, David C ^a  

^a Arizona Oncology Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; DISEASE FREE SURVIVAL; HUMAN; MALE; METHODOLOGY; MORTALITY; PATIENT SELECTION; PRACTICE GUIDELINE; PROSTATE TUMOR; REVIEW; SALVAGE THERAPY; SURVIVAL RATE;

BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; PATIENT SELECTION; PRACTICE GUIDELINES; PROSTATIC NEOPLASMS; SALVAGE THERAPY; SURVIVAL RATE;

EID: 1542607800     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. CA: Cancer J Clin 52:23-47, 2002.
2. Grossfeld GD, Li YP, Lubeck DP, et al: Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: Data from cancer of the prostate strategic urologic research endeavor, 2002. J Urol 168:530-535, 2002.
3. Moul JW: Treatment options for prostate cancer: Part 1-stage, grade, PSA, and changes in the 1990's. Am J Manag Care 4:1031-1036, 1998.
4. Mettlin CJ, Murphy GP, McDonald CJ, et al: The National Cancer data base report on increased use of brachytherapy for the treatment of patients with prostrate carcinoma in the U.S. Cancer 86:1877-1882, 1999.
5. Stephenson RA, Stanford JL: Population-based prostate cancer trends in the United States: Patterns of change in the era of prostate-specific antigen. World J Urol 15:331-335, 1997.
6. The American Society for Therapeutic Radiology and Oncology (ASTRO) 1997 Consensus Panel (Cox J, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF): Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. J Clin Oncol 17:1155-1163, 1999.
7. Kuban DH, El-Mahdi AN, Schellhammer PF: Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma. Cancer 63:2421-2425, 1989.
8. D'Amico AV, Cote K, Loffredo M, et al: Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 169:1320-1324, 2003.
9. Pound CR, Partin AW, Eisenberger MA, et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591-1597, 1999.
10. Shipley W-U, Thames RD, Sandler HM, et al: Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. JAMA 281:598-1604, 1999.
11. Stephenson RA: Population-based prostate cancer trends in the PSA-era: Data from the Surveillance, Epidemiology, and End Results (SEER) program. Monogr Urol 19:1-19,1998.
12. Schild SE, Buskirk SJ, Robinow JS, et al: The result of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int J Radiat Oncol Biol Phys 23:141-145, 1992.
13. Vicini FA, Ziaja EL, Kestin LL, et al: Treatment outcome widi adjuvant and savage irradiation after radical prostatectomy for prostate cancer. Urology 54:111-117, 1999.
14. Raymond JF, Vuong M, Russell KJ: Neutron beam radiotherapy for recurrent prostate cancer following radical prostatectomy. Int J Radiat Oncol Biol Phys 41:93-99, 1998.
15. Wu JJ, King SC, Montana GS, et al: The efficacy of post-prostatectomy radiotherapy in patient with an isolate elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 32:317-323, 1995.
16. Tefilli MV, Gheiler EL, Tuguert R, et al: Salvage surgery or salvage radiotherapy for locally recurrent prostate cancer. Urology 52:224-229, 1998.
17. Beyer DC: Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54:880-883, 1999.
18. Partin AW, Pearson JD, Landis PK, et al: Evaluation of serum prostate-specific antigen velocity after radical prostatectomy of distinguish local recurrence from distant metastases. Urology 43:649-659, 1994.
19. Hanks GE, D'Amico A, Epstein BE, et al: Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time: Int J Radiat Oncol Biol Phys 27:125-127, 1993.
20. Goffinet DR, Martinez A, Freiha, F, et al: Iodine prostate implants for recurrent carcinomas after external beam irradiation: Preliminary results. Cancer 45:2717-2724, 1980.
21. Wallner KE, Nori D, Morse MJ, et al: Iodine re-implantation for locally progressive prostatic carcinoma. J Urol 144:704-706, 1990.
22. Loening SA, Turner JW: Use of percutaneous transperineal 198 An seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy. Prostate 23:283-290, 1993.
23. Grado GL, Collns JM, Kriegshauser JS, et al: Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53:2-10, 1999.
24. Beyer DC: Brachytherapy for recurrent prostate cancer. Semin Radiat Oncol 13:158-165, 2003.
25. Battermann JJ: Feasibility of permanent implant for prostate cancer after previous radiotherapy in the true pelvis. Radiother Oncol 57:297-300, 2000.
26. Sylvester J, Grimm P, Blasko J, et al: Transperineal permanent brachytherapy for local recurrence following external beam radiation for early-stage prostate cancer. J Brachyther Int 17:181-188, 2001.
27. Zincke H: Radical prostatectomy and exenterative procedures for local failure after radiotherapy with curative intent: Comparison of outcomes. J Urol 147: 894-899, 1992.
28. Cheng L, Sebo TJ, Slezak J, et al: Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer 83:2164-2171, 1998.
29. Ahlering TE, Lieskovsky G, Skinner DG: Salvage surgery plus androgen deprivation for radio-resistant prostatic adenocarcinoma. J Urol 147:900-902, 1992.
30. Rogers E, Ohori M, Kassabian VS, et al: Salvage radical prostatectomy: Outcome measured by serum prostate specific antigen levels. J Urol 153:104-110, 1995.
31. Lerner SE, Blute ML, Zincke H: Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol 154:1103-1109, 1995.
32. Miller RJ Jr, Cohen JK, Shuman B, et al: Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma. Cancer 77:1510-1514, 1996.
33. Pisters LL, Von Eschenbach AC, Scott SM, et al: The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157:921-925, 1997.
34. Lee F, Balm DK, McHugh TA, et al: Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring - a one year follow-up. Anticancer Resource 17:1511-1515, 1997.
35. De La Taille A, Hayek O, Benson MC, et al: Salvage cryotherapy for recurrent prostate cancer after radiation therapy: The Columbia experience. Urology 55:79-84, 2000.